Cargando…
COVID‐19 and (hydroxy)chloroquine–azithromycin combination: Should we take the risk for our patients?
Autores principales: | Javelot, Hervé, El‐Hage, Wissam, Meyer, Guillaume, Becker, Guillaume, Michel, Bruno, Hingray, Coraline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256125/ https://www.ncbi.nlm.nih.gov/pubmed/32350872 http://dx.doi.org/10.1111/bcp.14335 |
Ejemplares similares
-
Psychoactive compounds as multifactorial protection factors against COVID-19
por: Javelot, Hervé, et al.
Publicado: (2020) -
COVID-19: urgency for distancing from domestic violence
por: Ertan, Deniz, et al.
Publicado: (2020) -
Towards a pharmacochemical hypothesis of the prophylaxis of SARS-CoV-2 by psychoactive substances
por: Javelot, Hervé, et al.
Publicado: (2020) -
COVID-19 and its psychological consequences: Beware of the respiratory subtype of panic disorder
por: Javelot, Hervé, et al.
Publicado: (2020) -
Post-traumatic stress disorder following childbirth
por: Ertan, Deniz, et al.
Publicado: (2021)